Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.29 USD
−28.24 M USD
258.21 M USD
228.41 M
About ADMA Biologics Inc
Sector
Industry
CEO
Adam S. Grossman
Website
Headquarters
Ramsey
Founded
2004
FIGI
BBG002NCK5M5
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Market update 6/2/2024Just going through the usual updates. I'm mostly doing these videos for myself kind of like a trading journal and also to look back on it later whether I was right or wrong about some things. I don't have notes and I completely improvise it so I probably misspeak sometimes, also that's why there's n
adma2.5% position, as it is hard for me to manage us markets overnight.
earnings surprise continuation.
stop is close under structure. It should not close under 10 ema but that stop would be to far at the start.
it is soon time to sit and wait how things play out.
ADMA daily reversal on high volumeDaily price candle reversal to the upside on a 3X daily average volume (due to a large 2M buy order at 12:10pm EST) at major demand zone $3.20 - $3.37.
Double digit y-o-y revenue growth, improving quarterly earnings (EPS loss decreasing), EPS to turn positive by end 2024 or early 2025. Next catalys
ADMA. Back to history area.ADMA. Back to history area.
Squeezed too low. High insider, high institional value.
ADMA BIOLOGICS Stock Chart Fibonacci Analysis 050423Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 3.38/61.80%
AdmaBiologics stock analysisThere might be a " head and shoulders " pattern.
Otherwise, buying may be possible when the stochastic indicator or MACD indicator forms a golden cross .
ADMA Break OutThe MACD recentlty crossed and both the short and long term force index turned positive.
The 8/11 candle broke above resistance and closed there, taking out the 1 Fibonacci level while doing so. Despite the long upper wick on 8/11, the 8/12 candle closed above the prior close and also closed above
Relative Strength in Biotech - ADMA (1/5) To highlight my point in the previous $VIVO post, here are 5 other charts in the Biotech sector that have shown relative strength lately. Don't get me wrong, the market is still on a downtrend, but should we reverse and start a new uptrend, this sector may potentially be the next one to lead a
Long
Preferred Stock
The Company is currently authorized to issue up to 10 million shares of preferred stock, $0.0001, par value per share. There were no shares of preferred stock outstanding at September 30, 2021 and December 31, 2020.
Common Stock
As of September 30, 2021 and December 31, 2020, the
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ADMA is 21.37 USD — it has increased by 3.59% in the past 24 hours. Watch ADMA Biologics Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ADMA Biologics Inc stocks are traded under the ticker ADMA.
ADMA stock has fallen by −3.35% compared to the previous week, the month change is a 36.20% rise, over the last year ADMA Biologics Inc has showed a 431.59% increase.
We've gathered analysts' opinions on ADMA Biologics Inc future price: according to them, ADMA price has a max estimate of 26.00 USD and a min estimate of 24.00 USD. Watch ADMA chart and read a more detailed ADMA Biologics Inc stock forecast: see what analysts think of ADMA Biologics Inc and suggest that you do with its stocks.
ADMA reached its all-time high on Nov 11, 2024 with the price of 23.64 USD, and its all-time low was 1.01 USD and was reached on Oct 21, 2021. View more price dynamics on ADMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ADMA stock is 4.52% volatile and has beta coefficient of 2.02. Track ADMA Biologics Inc stock price on the chart and check out the list of the most volatile stocks — is ADMA Biologics Inc there?
Today ADMA Biologics Inc has the market capitalization of 5.05 B, it has decreased by −3.91% over the last week.
Yes, you can track ADMA Biologics Inc financials in yearly and quarterly reports right on TradingView.
ADMA Biologics Inc is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ADMA earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.13 USD resulting in a 25.37% surprise. The estimated earnings for the next quarter are 0.15 USD per share. See more details about ADMA Biologics Inc earnings.
ADMA Biologics Inc revenue for the last quarter amounts to 119.84 M USD, despite the estimated figure of 105.81 M USD. In the next quarter, revenue is expected to reach 113.38 M USD.
ADMA net income for the last quarter is 35.91 M USD, while the quarter before that showed 32.06 M USD of net income which accounts for 12.00% change. Track more ADMA Biologics Inc financial stats to get the full picture.
No, ADMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 624.00 employees. See our rating of the largest employees — is ADMA Biologics Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADMA Biologics Inc EBITDA is 123.10 M USD, and current EBITDA margin is 11.60%. See more stats in ADMA Biologics Inc financial statements.
Like other stocks, ADMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADMA Biologics Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADMA Biologics Inc technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADMA Biologics Inc stock shows the buy signal. See more of ADMA Biologics Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.